TEKTON RESEARCH
Tekton Research is a physician-led, multi-site clinical research organization operating 25+ sites across 9 US states, conducting Phase 1-4 clinical trials in neuroscience, cardiometabolic, general medicine, infectious disease, and pediatrics for pharmaceutical sponsors, CROs, and biotech companies. Founded in 2006; majority-owned by Havencrest Capital Management since 2023.
- Company typePrivate
- Founded2006
- HeadquartersAustin, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What TEKTON RESEARCH does
Tekton Research is a physician-led, multi-site clinical research organization founded in 2006 and headquartered in Austin, Texas. The company operates more than 25 research sites across nine US states (Texas, Colorado, Oklahoma, Kansas, New Jersey, Georgia, Virginia, Ohio, and Missouri), executing Phase 1-4 clinical trials in neuroscience and psychiatry, cardiometabolic and endocrine, general medicine, infectious disease and vaccines, and pediatrics. Its core product is a distributed site network that delivers patient enrollment, data collection, rater-calibrated CNS assessments, and regulatory-compliant site operations on behalf of study sponsors. Tekton monetizes through professional-services fees billed per patient enrolled, per visit completed, and per protocol complexity to pharmaceutical sponsors, contract research organizations (CROs), and biotech companies; per-patient participant compensation is structured separately and is not a revenue stream for the company.
The company's go-to-market is sales-led, with a business development team engaging enterprise sponsors and CROs directly, supported by participation in industry conferences (EASD, SCRS Global Site Solutions Summit, CNS Summit, Obesity Week, AES), content marketing, and partnerships with SCRS and AMRC. Tekton holds alliance relationships with named CROs including Parexel (Alliance Site) and Worldwide Clinical Trials, and has a strategic partnership with Summit Clinical Research for MASH/NASH trials. On the technology side, Tekton deployed Todata Analytics' SiteGrades platform and Tod AI layer as an enterprise business intelligence layer across its network in November 2025 to support data analysis and capacity planning. Operational performance metrics include sub-24-hour site activation, 95% participant retention, and a 20.3-day average contract turnaround against an industry benchmark of 30+ days.
Since September 2023, Tekton has operated as a majority-owned portfolio company of Havencrest Capital Management. Under that ownership, the company has pursued an active growth agenda: multi-state site expansion (Ohio and New Jersey in November 2025; San Antonio multi-specialty hub in April 2026), senior leadership additions across commercial and therapeutic-area functions, and entry into new therapeutic verticals such as MASH/NASH. The company employs between 51 and 100 staff, with its distributed site footprint forming the bulk of operational capacity.
TEKTON RESEARCH firmographics
Firmographics- Name
- TEKTON RESEARCH
- Legal name
- Tekton Research
- Website
- https://tektonresearch.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Tekton Research is a physician-led, multi-site clinical research organization operating 25+ sites across 9 US states, conducting Phase 1-4 clinical trials in neuroscience, cardiometabolic, general medicine, infectious disease, and pediatrics for pharmaceutical sponsors, CROs, and biotech companies. Founded in 2006; majority-owned by Havencrest Capital Management since 2023.
- Ownership category
- akta.pro rank
TEKTON RESEARCH industry classification
Industry- Product category
- Clinical Research Site Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where TEKTON RESEARCH is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices22 records
Markets served
TEKTON RESEARCH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Services: Revenue is generated through fees charged to pharmaceutical sponsors, CROs, and biotech companies for conducting clinical trials at Tekton's network of physician-led research sites. Fees are typically structured per patient enrolled, per visit completed, and according to protocol complexity. The company operates as a site network providing patient enrollment, data collection, regulatory compliance, and site operations services to study sponsors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Study-specific participant compensation |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
TEKTON RESEARCH product offering
Product offeringCore offering
Tekton Research operates a network of 25+ physician-led clinical research sites across 9 U.S. states, conducting Phase 1–4 clinical trials for pharmaceutical sponsors, CROs, and biotech companies. The organization provides patient enrollment, site operations, data collection, regulatory compliance, and rater-calibrated assessments across therapeutic areas including neurology, psychiatry, cardiometabolic disease, infectious disease, general medicine, and pediatrics.
Differentiator
Problem solved
Functional benefit
Products and services
- Neurology & Psychiatry Clinical Trials Phase 1-4 CNS clinical trial services covering depression, pain, Alzheimer's disease, migraine, addiction, and other neurologic and psychiatric conditions, with experienced investigators and calibrated rater training for rater-dependent studies.
- Cardiometabolic & Endocrine Clinical Trials Clinical trial services for Type 1 and Type 2 diabetes, obesity, MASH/MASLD, thyroid conditions, and related metabolic disorders, staffed by board-certified endocrinologists and obesity medicine specialists.
- Vaccines & Infectious Disease Trials Vaccine and infectious disease trial services across 20+ sites covering flu, RSV, COVID-19, hMPV, herpes, combination vaccines, and diagnostic studies.
- General Medicine Clinical Trials General medicine clinical trial services covering allergy, COPD, asthma, atopic dermatitis, and other common chronic conditions, leveraging large, well-profiled patient populations.
- Pediatric Clinical Trials Pediatric clinical trial services across dedicated pediatric sites supporting studies in pediatric populations alongside adult and maternal populations.
- San Antonio Multi-Specialty Clinical Research Hub Multi-specialty clinical research hub in San Antonio, Texas, serving pharmaceutical sponsors and CROs running cardiometabolic and endocrine trials with concentrated physician-led capacity.
Quantifiable outcome
- 95% participant retention rate
- +3 more outcomes
Companies that use TEKTON RESEARCH
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles2 records
TEKTON RESEARCH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
TEKTON RESEARCH partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered strategic, core and partner.
- Todata AnalyticsstrategicTekton selected Todata's SiteGrades platform and Tod AI layer as enterprise business intelligence solutions to support expansion to 25+ research sites. The analytics tools aim to streamline data analysis and capacity planning across the network, particularly in neurology, cardiometabolic, and vaccine research.
- Summit Clinical ResearchcoreStrategic partnership to expand into MASH/NASH clinical trials. The collaboration launched at Tekton's Yukon, Oklahoma site under PI Dr. Robert Lockwood. Summit provides specialized support including investigator onboarding, protocol training, regulatory readiness, and ongoing mentorship. Within 5 days of activation, the first patient was screened.
- Worldwide Clinical TrialspartnerPartner logo displayed on Tekton Research website indicating collaborative working relationship for clinical trial execution.
- ParexelpartnerParexel Alliance Site partnership. Tekton is recognized as a Parexel Alliance Site partner for clinical trial execution.
- BEKHealthpartnerPartner logo displayed on website indicating collaborative relationship for site operations and patient recruitment technology.
- SCRS - Society for Clinical Research SitespartnerPartnership with SCRS for industry engagement, thought leadership, and representation in the clinical research site community. Tekton participates in SCRS events and podcast series.
- Advarra Clinical ConductorpartnerPartner logo displayed indicating use of Advarra Clinical Conductor for clinical trial management and regulatory compliance.
- CITI-ProgrampartnerPartner logo displayed indicating use of CITI-Program for research ethics training and compliance.
- AMRC - Association of Multisite Clinical Research CorporationspartnerMember of AMRC, the Association of Multisite Clinical Research Corporations, representing the interests of multi-site research organizations.
- ComplionpartnerPartner logo displayed indicating use of Complion for document management and compliance solutions.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
TEKTON RESEARCH competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: Velocity Clinical Research is a PE-backed (GHO Capital) multi-site clinical research organization operating a comparable U.S. site network. It is the most structurally similar competitor, with parallel physician-led model, therapeutic breadth, and roll-up growth strategy.
- Flourish Research: Flourish Research is a multi-site clinical research organization operating integrated research sites across multiple U.S. states with a similar physician-led model. Comparable in therapeutic breadth and operational positioning to Tekton.
- Summit Clinical Research: Summit Clinical Research is a specialty site network focused on MASH/NASH and metabolic disease trials. Although Tekton's strategic partner, Summit operates its own competing site network targeting the same cardiometabolic sponsors.
Broad incumbents
- Medpace: Medpace is a mid-size full-service CRO with a meaningful dedicated clinical trial site network across the U.S. and Europe. It competes for sponsor and CRO site-selection decisions, but operates a much broader service portfolio than Tekton's site-only model.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO with significant CNS and cardiometabolic focus. While listed as a Tekton partner, it also operates its own investigator site relationships and competes for the same sponsor study awards.
- ICON plc: ICON plc is one of the largest global CROs with extensive site network capabilities through its acquired site alliances and embedded site services. Competes for large sponsor programs where Tekton is often a sub-site partner.
- IQVIA: IQVIA is the world's largest CRO with a vast global site network and full-service capabilities. Represents the upper bound of the competitive landscape and the preferred-provider alternative for large pharma sponsors.
- Labcorp Drug Development: Labcorp Drug Development (formerly Covance) is a top-tier global CRO offering both central laboratory services and clinical trial site network capabilities. Competes in the same sponsor contracts Tekton targets, particularly for integrated lab + site programs.
- Parexel: Parexel is a global CRO with deep CNS and oncology expertise and an established Alliance Site network that includes Tekton. Competes with Tekton for sponsor site-selection decisions but also routes selected studies through Tekton via the Alliance program.
- Syneos Health: Syneos Health is a global biopharmaceutical solutions provider with combined CRO and commercial capabilities, including site network services. Competes in sponsor preferred-provider decisions and has overlap with Tekton's therapeutic focus areas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
TEKTON RESEARCH social profiles
Digital presenceTEKTON RESEARCH financial estimates
Financial estimateRevenue estimate
Valuation estimate
TEKTON RESEARCH leadership team
Management profileNumber of profiles
Profiles5 records
TEKTON RESEARCH funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TEKTON RESEARCH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TEKTON RESEARCH
What does TEKTON RESEARCH do?
Tekton Research operates a network of 25+ physician-led clinical research sites across 9 U.S. states, conducting Phase 1–4 clinical trials for pharmaceutical sponsors, CROs, and biotech companies. The organization provides patient enrollment, site operations, data collection, regulatory compliance, and rater-calibrated assessments across therapeutic areas including neurology, psychiatry, cardiometabolic disease, infectious disease, general medicine, and pediatrics.
Is TEKTON RESEARCH a public or private company?
TEKTON RESEARCH is a private company. It is classified as private equity controlled and is currently operating.
When was TEKTON RESEARCH founded?
TEKTON RESEARCH was founded in 2006. It employs 51 to 100 people.
Where is TEKTON RESEARCH based?
TEKTON RESEARCH is headquartered in Austin, United States, in the North America region.
How does TEKTON RESEARCH make money?
One revenue line is on record: clinical Trial Services.
Who are TEKTON RESEARCH's main competitors?
Direct peers on record are Velocity Clinical Research, Flourish Research and Summit Clinical Research. Broad incumbents are Medpace, Worldwide Clinical Trials, ICON plc, IQVIA, Labcorp Drug Development, Parexel and Syneos Health.
Does TEKTON RESEARCH have an API?
No public API is recorded for TEKTON RESEARCH.
What industry is TEKTON RESEARCH in?
TEKTON RESEARCH's product category is Clinical Research Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8000.